Susquehanna International Group
FULC icon

Susquehanna International Group’s Fulcrum Therapeutics FULC Stock Holding History

Susquehanna International Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Sell
83,700
-27,100
-24% -$251K ﹤0.01% 9021
2025
Q4 		$1.25M Buy
110,800
+97,300
+721% +$990K ﹤0.01% 6652
2025
Q3 		$124K Sell
13,500
-12,200
-47% -$88.3K ﹤0.01% 11426
2025
Q2 		$177K Buy
+25,700
New +$137K ﹤0.01% 11339
2025
Q1 		– Sell
-19,900
Closed -$93.5K – 12809
2024
Q4 		$93.5K Sell
19,900
-151,300
-88% -$558K ﹤0.01% 11392
2024
Q3 		$611K Buy
+171,200
New +$1.27M ﹤0.01% 7982
2024
Q2 		– Sell
-19,500
Closed -$184K – 12411
2024
Q1 		$184K Sell
19,500
-43,000
-69% -$384K ﹤0.01% 10690
2023
Q4 		$422K Sell
62,500
-105,000
-63% -$466K ﹤0.01% 9074
2023
Q3 		$744K Buy
167,500
+116,600
+229% +$510K ﹤0.01% 7309
2023
Q2 		$168K Buy
50,900
+34,200
+205% +$100K ﹤0.01% 10454
2023
Q1 		$47.6K Sell
16,700
-2,400
-13% -$21.5K ﹤0.01% 11717
2022
Q4 		$139K Buy
19,100
+3,400
+22% +$22.2K ﹤0.01% 10599
2022
Q3 		$127K Sell
15,700
-13,700
-47% -$98.1K ﹤0.01% 11454
2022
Q2 		$144K Buy
29,400
+18,700
+175% +$183K ﹤0.01% 11077
2022
Q1 		$253K Sell
10,700
-5,800
-35% -$82.1K ﹤0.01% 10698
2021
Q4 		$292K Sell
16,500
-6,200
-27% -$123K ﹤0.01% 10560
2021
Q3 		$640K Buy
+22,700
New +$430K ﹤0.01% 8744

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Susquehanna International Group's FULC Position: Q1 2026 in Review

Susquehanna International Group increased its Fulcrum Therapeutics (FULC) stake by 15% in Q1 2026, buying an estimated $124K and bringing the position to 101,336 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #8543.

Susquehanna International Group first reported a position in FULC in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.3M in Q1 2024. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Susquehanna International Group held 101,336 shares of Fulcrum Therapeutics worth $777K as of Q1 2026.
  • Susquehanna International Group bought 13,406 Fulcrum Therapeutics shares in Q1 2026, an estimated $124K.
  • Fulcrum Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8543 holding.
  • Susquehanna International Group first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • Susquehanna International Group's Fulcrum Therapeutics position peaked at $5.3M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.